Sponsor pipeline

Sichuan Baili Pharmaceutical Co., Ltd. clinical trial pipeline

Get alerts when Sichuan Baili Pharmaceutical Co., Ltd.'s trials change

135 active trials 80 recruiting 35 Phase 3 32 disease areas 9 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-10-01
notable
NCT07729956 A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1… · Phase 3
2026-10-02
notable
NCT07763639 A Study of SI-B036 in Patients With Locally Advanced or Metastatic Head and Neck Tumors… · Phase 1
2026-09-23
notable
NCT07763652 A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal… · Phase 1
2026-09-11
notable
NCT07255872 A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax +… · Phase 2/3
2026-09-11
notable
NCT07640789 A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in… · Phase 3
2026-09-15
notable
NCT07678957 A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing… · Phase 2
2026-09-11
notable
NCT07753226 A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and… · Phase 1
2026-09-05
notable
NCT07678970 A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal… · Phase 1
2026-09-16
notable
NCT07783321 A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following… · Phase 3

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-25 NCT07841925 A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other… Phase 1/2 Not Yet Recruiting
2026-09-23 NCT07837622 A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma… Phase 2 Not Yet Recruiting
2026-09-18 NCT07827261 A Study of BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally… Phase 2 Not Yet Recruiting
2026-09-14 NCT07818486 A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and… Phase 1/2 Not Yet Recruiting
2026-09-14 NCT07818499 A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large… Phase 1/2 Not Yet Recruiting

Active trials by phase

Phase 1
45
Phase 1/2
19
Phase 2
36
Phase 2/3
8
Phase 3
27

Active trials top 25 of 135

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07729956 A Study of BL-B01D1 Plus an Anti-PD-1 Antibody Versus Nab-paclitaxel Plus an Anti-PD-1… Triple-Negative Breast Cancer (TNBC) Recruiting 2026-09-30
NCT07640789 A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in… Non-small Cell Lung Cancer Stage III Recruiting 2026-09-10
NCT07502300 A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing… Extensive-stage Small-cell Lung Cancer Recruiting 2026-07-27
NCT07582315 A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally… Biliary Tract Cancer Recruiting 2026-07-24
NCT07606599 A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… Biliary Tract Cancer Recruiting 2026-07-24
NCT07648914 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… Breast Cancer Recruiting 2026-07-23
NCT07518147 A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in… Gastric Cancer Recruiting 2026-07-08
NCT06994195 A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients… Epithelial Ovarian Cancer Recruiting 2026-07-07
NCT07518173 A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and… HER2-positive Breast Cancer Recruiting 2026-06-04
NCT06838273 A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line… Non-small Cell Lung Cancer Recruiting 2026-04-20
NCT06857175 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… Urothelial Carcinoma Recruiting 2026-04-20
NCT06830889 A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer… HER2-positive Breast Cancer Recruiting 2026-01-22
NCT06957886 A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With… HER2-low Breast Cancer Recruiting 2026-01-21
NCT07152405 A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With… Gastric Adenocarcinoma Recruiting 2025-11-17
NCT07178795 A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of… Non-squamous Non-small Cell Lung Cancer Recruiting 2025-11-17
NCT07783321 A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following… Nasopharyngeal Carcinoma (NPC) Not Yet Recruiting 2026-09-15
NCT07730489 A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+… Colorectal Cancer Not Yet Recruiting 2026-08-27
NCT06304974 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… Esophageal Squamous Cell Carcinoma Active, Not Recruiting 2026-07-23
NCT06316531 A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or… HER2-positive Breast Cancer Active, Not Recruiting 2026-07-23
NCT06343948 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… HR+HER2- Breast Cancer Active, Not Recruiting 2026-07-23
NCT06382116 A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally… Non-small Cell Lung Cancer Active, Not Recruiting 2026-07-23
NCT06382142 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… Triple-Negative Breast Cancer Active, Not Recruiting 2026-07-23
NCT07545460 A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With… Epithelial Ovarian Cancer Not Yet Recruiting 2026-06-29
NCT06118333 A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With… Nasopharyngeal Carcinoma Active, Not Recruiting 2026-04-17
NCT06382129 A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced… Non-small Cell Lung Cancer Active, Not Recruiting 2026-04-17

Disease areas by active trials, top 10 of 32

Get alerts when Sichuan Baili Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free